8-KShareholder Matters

Cigna Group 8-K Report, Shareholder Vote Results (Apr 24, 2020)

Filed April 24, 2020For Securities:CI

Summary

This 8-K filing from Cigna Group (CI) details the results of its Annual Meeting of Shareholders held on April 22, 2020. The meeting saw high shareholder participation, with over 90% of outstanding shares represented. The primary focus was on the election of the Board of Directors, advisory approval of executive compensation, and ratification of the independent auditor. All director nominees received overwhelming support, indicating shareholder confidence in the current leadership. Furthermore, shareholders provided advisory approval for the company's executive compensation. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2020 was also overwhelmingly ratified. However, two shareholder proposals, one regarding the right to call a special meeting and another on gender pay gap reporting, did not receive majority support, suggesting differing views on these specific corporate governance matters among the shareholder base.

Key Highlights

  • 1All 12 director nominees for Cigna's Board of Directors were elected for one-year terms with substantial 'For' votes.
  • 2Shareholders provided advisory approval for the company's executive compensation plan.
  • 3PricewaterhouseCoopers LLP was ratified as Cigna's independent registered public accounting firm for 2020 with strong shareholder support.
  • 4A shareholder proposal seeking the right to call a special meeting did not pass, receiving less than majority support.
  • 5A shareholder proposal requesting gender pay gap reporting also failed to gain majority approval from shareholders.
  • 6A significant majority (90.67%) of Cigna's outstanding shares were represented at the Annual Meeting, indicating active shareholder engagement.

Frequently Asked Questions

The primary outcomes included the election of all 12 director nominees, advisory approval of executive compensation, and ratification of the company's independent auditor, PricewaterhouseCoopers LLP. However, two shareholder proposals on special meeting rights and gender pay gap reporting did not pass.

Shareholders provided advisory approval for Cigna's executive compensation. The proposal received approximately 268 million 'For' votes compared to around 48 million 'Against' votes.

Yes, two non-binding shareholder proposals did not receive majority support. These were a proposal regarding the right to call a special meeting and a proposal concerning gender pay gap reporting.

The high turnout (over 90% of shares represented) suggests a strong level of shareholder engagement and interest in the company's governance and strategic decisions.